Endometriosis and endometrial cancer are not the same condition. Endometriosis is a chronic, non-cancerous condition where tissue similar to the uterine lining grows outside the uterus. Endometrial cancer is a malignancy that develops inside the uterine lining itself. The two share a confusingly similar name and involve the same type of tissue, which is why many people wonder whether one leads to the other or whether they’re related. They are connected in some important ways, but they behave very differently in the body.
Where Each Condition Develops
Endometriosis involves endometrial-like tissue growing in places it doesn’t belong: the ovaries, fallopian tubes, the tissue lining your pelvis, and occasionally more distant sites like the bowel or diaphragm. This tissue responds to your hormonal cycle the same way your uterine lining does. It thickens, breaks down, and bleeds with each menstrual period, but because the blood has no way to exit your body, it causes inflammation, scarring, and adhesions that can bind organs together.
Endometrial cancer starts inside the uterus, in the lining (endometrium) where a pregnancy would normally implant. Cells in that lining accumulate enough genetic mutations to begin growing uncontrollably. Unlike endometriosis, which spreads tissue that still looks and functions relatively normally, endometrial cancer produces abnormal cells that can invade the muscular wall of the uterus and eventually spread to lymph nodes or distant organs.
Who Gets Each Condition
These two conditions typically affect women at very different life stages. Endometriosis is overwhelmingly a disease of the reproductive years, most commonly diagnosed between the ages of 25 and 40. It depends on estrogen to fuel the growth of displaced tissue, so symptoms often improve after menopause when estrogen levels drop.
Endometrial cancer, by contrast, is primarily diagnosed after menopause. The average age at diagnosis is around 60. Risk factors include obesity, prolonged estrogen exposure without adequate progesterone (such as from hormone replacement therapy or chronic irregular ovulation), and conditions like polycystic ovary syndrome. While younger women can develop endometrial cancer, it’s far less common before age 45.
How Symptoms Differ
Both conditions involve the pelvis, but they announce themselves differently. Endometriosis typically causes severe menstrual cramps that worsen over time, chronic pelvic pain that may not be limited to your period, pain during sex, painful bowel movements or urination during menstruation, and difficulty getting pregnant. The pain tends to be cyclical, tracking with your menstrual cycle, though advanced endometriosis can cause constant discomfort.
The hallmark symptom of endometrial cancer is abnormal uterine bleeding, particularly any vaginal bleeding after menopause. In premenopausal women, it may show up as unusually heavy periods or bleeding between periods. Pelvic pain is less prominent early on and typically only appears once the cancer has grown larger or spread. Some women also notice watery or blood-tinged vaginal discharge. Because postmenopausal bleeding is such a reliable early warning sign, endometrial cancer is often caught at an early, treatable stage.
The Biological Overlap
Despite being a non-cancerous condition, endometriosis shares several unsettling characteristics with malignant tissue. It invades surrounding structures, stimulates the growth of new blood vessels to feed itself, resists the normal cell-death signals that keep tissue growth in check, and establishes new growths in distant locations. These are all hallmarks of cancer biology, which is part of why the relationship between the two conditions has drawn so much research attention.
At the genetic level, the overlap is striking. Endometriotic tissue, particularly in ovarian cysts, frequently carries mutations in the same genes that drive the most common type of endometrial cancer. These mutations accumulate with age and with the number of menstrual cycles a woman experiences. The key difference is one of degree: endometrial cancer carries a significantly higher burden of mutations than either normal endometrial tissue or endometriotic tissue. The mutations present in endometriosis appear to be necessary but not sufficient for cancer to develop.
Does Endometriosis Raise Cancer Risk?
A large meta-analysis combining data from 13 studies found that women with endometriosis have roughly a 66% higher risk of developing endometrial cancer compared to women without it. That sounds alarming, but context matters. Endometrial cancer is not common to begin with. The lifetime risk for all women is around 3%, so a 66% relative increase brings the absolute risk to roughly 5%. The vast majority of women with endometriosis will never develop endometrial cancer.
The increased risk appears to apply specifically to type 1 endometrial cancer, the more common and generally less aggressive form. Researchers found no significant link between endometriosis and type 2 endometrial cancer, which is rarer and tends to be more aggressive. This makes biological sense, since type 1 tumors share the same genetic mutation patterns seen in endometriotic tissue.
The stronger cancer connection for endometriosis, however, is with ovarian cancer rather than endometrial cancer. Women with endometriosis face a 3.7 times greater risk of ovarian clear cell carcinoma and a 2.3 times greater risk of ovarian endometrioid carcinoma. These “endometriosis-associated ovarian cancers” are thought to develop directly from endometrial cysts on the ovaries. Roughly 75% of these ovarian cancers are the endometrioid subtype. Genomic sequencing has shown that in women who develop both ovarian and endometrial tumors, the cancers often share the same genetic origin, suggesting they arose from the same group of cells.
How Each Condition Is Diagnosed
The diagnostic paths for these two conditions look quite different. Endometriosis is notoriously difficult to diagnose. The gold standard is laparoscopic surgery, where a surgeon inserts a small camera through an incision near the navel to visually identify and biopsy endometrial implants. Imaging like ultrasound or MRI can detect larger endometriotic cysts (called endometriomas) on the ovaries but often misses smaller or flatter deposits. The average delay between the onset of symptoms and a confirmed diagnosis of endometriosis is 7 to 10 years.
Endometrial cancer is usually diagnosed through a tissue biopsy of the uterine lining. If you report abnormal bleeding, your doctor can take a small sample of endometrial tissue in the office, often without anesthesia, and send it to a lab. Ultrasound is frequently used first to measure the thickness of the uterine lining, since a thickened lining in a postmenopausal woman raises suspicion. The biopsy itself is definitive: it either shows cancer cells or it doesn’t.
How “Staging” Means Different Things
Both endometriosis and endometrial cancer are classified into stages, but the staging systems measure fundamentally different things. Endometriosis staging (stages I through IV) describes how much displaced tissue exists and how much scarring or adhesion has formed. Stage IV endometriosis means extensive disease with large cysts and dense adhesions. It does not mean the tissue is cancerous or life-threatening. A person with stage IV endometriosis may have debilitating pain and infertility, but the condition itself is not going to metastasize to the lungs or liver.
Endometrial cancer staging (also stages I through IV) tracks how far the cancer has invaded and spread. Stage I means the cancer is confined to the uterus. Stage IV means it has spread to the bladder, bowel, or distant organs. This staging directly determines prognosis and survival rates. The two staging systems happen to use the same numbering, but “stage IV” carries a completely different meaning and level of urgency in each condition.
Treatment Approaches
Because endometriosis is hormone-driven and non-cancerous, treatment focuses on managing pain and preserving fertility. Hormonal therapies that suppress estrogen, such as birth control pills, progestin-only options, or medications that temporarily induce a menopause-like state, can slow the growth of endometrial implants and reduce symptoms. When hormonal treatment isn’t enough, surgery to remove or destroy visible endometriotic tissue can provide relief, though the disease recurs in a significant number of cases. For women who are done having children and have severe symptoms, removal of the uterus and ovaries may be recommended as a more definitive option.
Endometrial cancer treatment is built around removing the cancer. The standard first step is surgery to remove the uterus, fallopian tubes, and ovaries. Depending on the stage and how aggressive the cancer cells appear under a microscope, radiation therapy or systemic treatment may follow. Early-stage endometrial cancer, which accounts for the majority of cases, has a five-year survival rate above 90%. More advanced disease requires more aggressive treatment and carries a lower survival rate, but even intermediate stages respond well to combined approaches.
The goals of treatment capture the core difference between these conditions. With endometriosis, the aim is to control a chronic disease and improve quality of life. With endometrial cancer, the aim is to eliminate a life-threatening growth before it spreads.